- Previous Close
24.40 - Open
24.45 - Bid 24.55 x --
- Ask 24.90 x --
- Day's Range
24.35 - 24.90 - 52 Week Range
23.90 - 29.30 - Volume
47,993 - Avg. Volume
173,180 - Market Cap (intraday)
2.513B - Beta (5Y Monthly) 0.37
- PE Ratio (TTM)
21.84 - EPS (TTM)
1.14 - Earnings Date --
- Forward Dividend & Yield 0.80 (3.21%)
- Ex-Dividend Date Jul 31, 2024
- 1y Target Est
--
Wellell Inc. provides medical solutions for healthcare professionals worldwide. The company offers wound management products, including Serene Air and Serene Elite, which are alternating pressure redistribution systems for patients with high to very high risk for pressure ulcers; ACS Turn, a low air lateral turning mattress; Pro-care Optima, an alternating pressure redistribution system for patients with high to very high risk of pressure injuries; Pro-care turn, a bilateral turning air mattress for patients with medium to high risk of pressure injuries; Domus Auto, Domus 4, and Verso for patients with medium to high risk of pressure injury; Domus 3 for patients with medium risk of pressure injury; Domus 2s for patients with low to medium risk of pressure injury; Domus 1 for patients in low risk of pressure injury; Sedens 500 and Sedens 400, which are seat cushions; and Flexi-Air, a non-powered hybrid mattress. It also provides respiratory therapy products, such as nasal masks, full face masks, nasal pillows mask, portable suction unit, and compressor nebulizers; iCH Auto and XT Auto for automatic positive airway pressure; XT Prime, XT Sense, and XT Fit for continuous positive airway pressure; XT Heated Humidifier for humidification; and medical equipment. The company was founded in 1990 and is based in New Taipei City, Taiwan.
www.wellell.com/enRecent News: 4106.TW
View MorePerformance Overview: 4106.TW
Trailing total returns as of 4/2/2025, which may include dividends or other distributions. Benchmark is TSEC CAPITALIZATION WEIGHTED ST (^TWII) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 4106.TW
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 4106.TW
View MoreValuation Measures
Market Cap
2.51B
Enterprise Value
2.02B
Trailing P/E
21.84
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.05
Price/Book (mrq)
1.04
Enterprise Value/Revenue
0.85
Enterprise Value/EBITDA
7.90
Financial Highlights
Profitability and Income Statement
Profit Margin
4.83%
Return on Assets (ttm)
2.59%
Return on Equity (ttm)
4.85%
Revenue (ttm)
2.39B
Net Income Avi to Common (ttm)
115.24M
Diluted EPS (ttm)
1.14
Balance Sheet and Cash Flow
Total Cash (mrq)
782.77M
Total Debt/Equity (mrq)
12.72%
Levered Free Cash Flow (ttm)
132.17M